BioCentury
ARTICLE | Company News

Adial, Cato BioVentures deal

November 11, 2013 8:00 AM UTC

ADial and VC firm Cato entered a deal under which the VC will invest $1.8 million in ADial in exchange for Cato's affiliate Cato Research Ltd. serving as ADial's preferred CRO for clinical trials of ...